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A B S T R A C T
Important reactions of drug metabolism, including UGT mediated glucuronidation and steroidsulfatase
mediated hydrolysis of sulfates, take place in the endoplasmic reticulum (ER) of hepatocytes.
Consequently, UGT generated glucuronides, like estradiol-17b-glucuronide, have to be translocated
back into the cytoplasm to reach their site of excretion. Also steroidsulfatase substrates, including
estrone-3-sulfate, have to cross the ER membrane to reach their site of hydrolysis. Based on their
physicochemical properties such compounds are not favored for passive diffusion and therefore likely
necessitate transport system(s) to cross the ER membrane in either direction.
The current study aims to investigate the transport of taurocholate, estradiol-17b-glucuronide, and
estrone-3-sulfate in smooth (SER) and rough (RER) endoplasmic reticulum membrane vesicles isolated
from Wistar and TR rat liver.
Time-dependent and bidirectional transport was demonstrated for taurocholate, showing higher
uptake rates in SER than RER vesicles. For estradiol-17b-glucuronide a fast time-dependent efﬂux with
similar efﬁciencies from SER and RER but no clear protein-mediated uptake was shown, indicating an
asymmetric transport system for this substrate. Estrone-3-sulfate uptake was time-dependent and
higher in SER than in RER vesicles. Inhibition of steroidsulfatase mediated estrone-3-sulfate hydrolysis
decreased estrone-3-sulfate uptake but had no effect on taurocholate or estradiol-17b-glucuronide
transport.
Based on inhibition studies and transport characteristics, three different transport mechanisms are
suggested to be involved in the transport of taurocholate, estrone-3-sulfate and estradiol-17b-
glucuronide across the ER membrane.
  2014  The  Authors.  Published  by Elsevier Inc.
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Biotransformation and elimination of endogenous and exoge-
nous compounds is an important function of the liver. The hepatic
drug elimination process occurs in hepatocytes and is classiﬁed
into four phases including drug uptake (phase 0), phase 1 and 2
biotransformation and excretion of metabolites (phase 3) [1]. Drug
uptake and metabolite excretion is accomplished by transport
proteins localized at the basolateral and canalicular membrane of
hepatocytes. The transport systems localized to the plasma
membrane are complemented by intracellular enzymes catalyzing
phase 1 and phase 2 reactions, converting poorly water-soluble
compounds into more water-soluble metabolites to enable their
excretion into the bile or the sinusoidal blood plasma. Phase 1
reactions are mainly accomplished by members of the cytochrome
P450 enzyme family (CYPs) preparing compounds for subsequent
phase 2 conjugation. A major phase 2 pathway represents the
conjugation with glucuronic acid mediated by the family of the
UDP-glucuronosyltransferases (UGTs) [2]. In humans, CYPs and
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hepatic elimination but also in the conjugation of endogenous
compounds, including estradiol or bilirubin [3]. Furthermore,
glucuronidation can represent an alternative detoxiﬁcation
pathway for bile acid elimination in cholestasis to protect
hepatocytes from the cytotoxic effect of bile acids in case of
accumulation [4]. Elimination of glucuronides into bile is accom-
plished by the multidrug resistance-associated protein 2 (MRP2),
which belongs to the ATP binding cassette (ABC) transporter
superfamily [5]. The lack of functional MRP2 is known to be
responsible for deﬁcient glucuronide excretion into bile, resulting
in glucuronide accumulation and conjugated hyperbilirubinemia,
known as Dubin Johnson syndrome in humans [6]. A correspond-
ing animal model are the so-called TR rats [7].
Both CYPs [8] as well as UGTs [9] are anchored in the membrane
of the endoplasmic reticulum (ER). In addition, steroidsulfatase
(STS, also known as estronesulfatase or arylsulfatase C), which is
important for steroid activation, is anchored as another metabo-
lizing enzyme in the ER membrane [10–12]. The ER is a
heterogenous compartment structurally divided into three sub-
compartments, including the nuclear envelope (NE), the smooth
(SER) and the rough (RER) endoplasmic reticulum [13]. The RER
harbours membrane bound ribosomes [14] and therefore is
involved in protein biosynthesis [15]. By contrast, the CYPs [8]
and UGTs [16] are localized in the SER. Besides in SER, UGTs have
also been detected in RER and the NE [16]. Localization of STS has
been identiﬁed in the ER and the NE in rat liver [17], but its
distribution between SER and RER is still unclear. Besides the
shared localization of CYPs, UGTs, and STS in the ER membrane,
these phase 1 and phase 2 enzymes differ in the localization of
their catalytic sites with respect to the cytoplasm. While the CYPs
have their catalytic site in the cytoplasm [18], the active sites of
UGTs [19] and STS [12] are located in the lumen of the ER.
Consequently, substrates of STS, like estrone-3-sulfate (E3S) or
dehydroepiandrosteronesulfate (DHEAS), have to cross the ER
membrane to reach their site of hydrolysis. Due to their
physicochemical properties, these compounds are not favored
for passive diffusion and very likely necessitate transport
system(s) to get access to the ER lumen. However, until now, no
data are available on the characterization of the transport of the
STS model substrate estrone-3-sulfate across the ER membrane.
Accordingly, the co-substrate for UGT mediated glucuronida-
tion, the uridine diphosphate glucuronic acid (UDPGA) has to be
translocated from its site of synthesis in the cytoplasm, to its site of
action within the ER lumen. After UGT mediated glucuronidation,
the resulting products have to be transported from the ER lumen
back into the cytoplasm. Based on their physicochemical proper-
ties neither UDPGA nor glucuronides are likely to cross the ER
membrane by simple diffusion, indicating the involvement of
transport system(s) in the translocation of these compounds across
the ER membrane. Evidence for the existence of such transport
system(s) is given as UDPGA transport has been reported in rat
liver microsomes [20]. Transport activity into microsomes isolated
from rat liver has also been shown for different glucuronides [21–
24]. However, only one study investigated transport of estradiol-
17b-glucuronide in ER enriched liver microsomes but this study
did not distinguish between SER and RER. Finally, carrier-mediated
transport of taurocholate (TC) into rat liver microsomes, largely
being composed of ER has been reported a while ago [25].
Based on the knowledge that STS and UGTs have their catalytic
site within the ER lumen, the present study investigated and
characterized the transport activity for the UGT model product
estradiol-17b-glucuronide (E17bG) as well as the STS model
substrate estrone-3-sulfate (E3S) in SER and RER vesicles isolated
from rat liver. Transport of sulfated and glucuronidated model
compounds across SER and RER membranes were functionallycompared. Furthermore, a potential impact of a chronic cyto-
plasmic accumulation of glucuronides on the activity of these
transport systems was investigated using ER fractions isolated
from wild type and from the TR rats. Finally, taurocholate
transport into RER and SER was investigated to test for potential
common transport pathways with phase 2 products.
2. Materials and Methods
2.1. Materials
[6,7-3H(N)]-estradiol-17b-glucuronide (E17bG, 41.8 Ci/mmol),
[6,7-3H(N)]-estrone-3-sulfate (E3S, 45.6 Ci/mmol), [3H(G)]-tauro-
cholic acid (TC, 5 Ci/mmol) as well as the liquid scintillation ﬂuid
Filter Count were purchased from Perkin-Elmer (Schwerzenbach,
Switzerland). Unlabelled substrates including E3S, E17bG, and TC
as well as valinomycin, puromycin, and ATP were purchased from
Sigma Aldrich (Buchs, Switzerland). Compounds used for inhibi-
tion studies, including UDP-glucuronic acid (UDPGA), Stx64, and
vanadate were purchased from Sigma Aldrich (Buchs Switzerland).
Glucose-6-phosphate was purchased from Roche (Basel,
Switzerland) and bovine serum albumin was purchased from
Interchim (Montluc¸on, France). All chemicals used were of the
highest purity available. HPTLC plates and solvents used for HPTLC
analysis were purchased from Merck (Darmstadt, Germany).
2.2. Animals
Wistar rats, obtained from Charles River (Charles River
Laboratories, Sulzfeld, Germany), Sprague Dawley rats obtained
from Harlan (Harlan Laboratories, Horst, Netherlands), and TR
rats (180–200 g), were held in the animal facilities of the
University Hospital of Zurich. The animals received humane care
in accordance with local and federal guidelines. Animal experi-
ments were approved by the local government’s animal care
committee.
2.3. Membrane vesicle isolation
2.3.1. Isolation of basolateral and canalicular membrane vesicles from
rat liver
Basolateral and canalicular membrane vesicles were isolated
from Sprague Dawley rats as described by Meier and colleagues
[26]. After isolation, vesicles were rapidly frozen and stored in
liquid nitrogen until use and protein content was measured using
the method of Lowry [27].
2.3.2. Isolation of smooth (SER) and rough (RER) endoplasmic
reticulum vesicles from rat liver
SER and RER vesicles were isolated from livers of overnight
fasted male Wistar and TR rats (150-200 g) by density gradient
centrifugation following procedures as described previously
(procedure B, [28]). After removal of the livers from the animals
all steps were performed on ice or in the cold room. After density
gradient centrifugation the SER fraction, located at the 0.6 M and
1.3 M sucrose interface, was collected by careful aspiration. The
pelleted RER was rehomogenized in 0.25 M sucrose in a glass
Teﬂon homogenizer at full speed. Subsequently, SER and RER
vesicles were recovered by centrifugation at 120 000 g for 45 min
at 4 8C. The supernatant was discarded and pelleted SER and RER
vesicles were resuspended in the desired resuspension buffer using
a 25G syringe needle. Vesicles were rapidly frozen and stored in
liquid nitrogen until use. Protein of SER and RER vesicles was
determined using bicinchoninic acid (Thermo Scientiﬁc, Waltham,
Massachusetts) and bovine serum albumin as standard.
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Proteins were separated by SDS-PAGE using 7.5% separating
gels followed by blotting on nitrocellulose membranes (GE
Healthcare, Little Chalfont, United Kingdom) with standard
procedures. Membrane fractions were probed for Cyp3a2 (Enzo
Lifesciences CR3320, Lausen, Switzerland; 1:7000 dilution),
Sec61a (Thermo Scientiﬁc PA3-014, Waltham, Massachusetts;
dilution 1:7000) or PDI (Thermo scientiﬁc MA3-019, Waltham,
Massachusetts; dilution 1:20 000 or 1:100 000) by either
incubation at 4 8C overnight (Sec61a) or at room temperature
for 2 h (Cyp3a2; PDI). Either HRP-conjugated goat anti rabbit IgG
(GE Healthcare RPN4301, Little Chalfont, United Kingdom; for
Sec61a and Cyp3a2; dilution 1:30 000) or sheep anti mouse IgG
(GE Healthcare NA931VS, Little Chalfont, United Kingdom; dilution
1:3000) was used as secondary antibody. All antibodies were
diluted in TBS-T (150 mM NaCl, 10 mM Tris/HCl pH 7.6, 0.1%
Tween 20) containing 5% milk powder. UptiLightTM (Interchim,
Montluc¸on, France) was used as chemiluminescent substrate for
protein detection. Western blot analyses for Cyp3a2 and Sec61a
were performed for each SER and RER isolation used in this study.
Primary antibodies against Oatp1a1 [29], Ntcp [30], and Mrp2
[31] were used in 1:1000, 1:5000, and 1:2000 dilutions in 5% milk/
TBS-T, respectively. For stripping off antibodies, nitrocellulose
membranes were incubated for 30 min at room temperature in
stripping buffer (100 mM NaCl, 100 mM glycine, pH adjusted to 3.0
with HCl) followed by three washing steps in TBS-T for 10 min.
Incubation with secondary HRP-conjugated goat anti rabbit IgG
(GE Healthcare RPN4301, Little Chalfont, United Kingdom) and
protein detection with UptiLightTM (Interchim, Montluc¸on, France)
was performed as described above.
2.5. Transport studies
2.5.1. Vesicle uptake studies
Uptake of radioactive labelled substrates was measured by the
rapid ﬁltration method [32]. Vesicles were quickly thawed in a 37 8C
waterbath, diluted to a protein concentration of 3.5 mg/ml with the
appropriate resuspension buffer and revesiculated by 20 time
aspiration through a 25G needle with a syringe. 20 ml (70 mg) of
vesicles were prewarmed at 37 8C for 30 sec and uptake was
initiated by the addition of 80 ml of incubation buffer containing the
tritiated substrate. After the desired time of incubation transport
was stopped by the addition of 3 ml ice-cold stop solution (50 mM
sucrose, 100 mM KCl, 0.1 mM Ca(gluconate)2, 5 mM MgCl2 and
20 mM Hepes/Tris pH 7.4) and solution was rapidly ﬁltered through
a 0.45 mm nitrocellulose acetate ﬁlter (Sartorius, Go¨ttingen,
Germany). For TC transport studies, ﬁlters were presoaked with
3 ml of 1 mM TC solution. Filters were dissolved in Filter Count
(Perkin Elmer, Schwerzenbach, Switzerland) and radioactivity was
measured by liquid scintillation counting in a Betacounter (Perkin
Elmer, Schwerzenbach, Switzerland).
2.5.1.1. Transport studies at different membrane potentials. To test
for the role of the membrane potential on transport activities,
vesicles were pretreated with valinomycin (10 mg valinomycin per
mg protein), added from a stock solution (10 mg/ml in DMSO), for
30 min at room temperature followed by 30 min incubation on ice
prior to transport studies. Subsequently a membrane potential was
generated by either an inward or outward directed potassium
gradient. To generate an inward positive membrane potential,
vesicles were resuspended in 250 mM sucrose, 0.1 mM Ca(gluco-
nate)2, 20 mM Hepes/Tris, pH 7.4 (Kout > Kin resuspension buffer)
and substrate containing incubation buffer (Kout > Kin incubation
buffer) consisted of 50 mM sucrose, 100 mM Kgluconate, 0.1 mM
Ca(gluconate)2, 2.5 mM Mg(gluconate)2, 20 mM Hepes/Tris pH 7.4.Contrary, an inside negative membrane potential was generated by
using 50 mM sucrose, 100 mM Kgluconate, 0.1 mM Ca(gluconate)2,
20 mM Hepes/Tris pH 7.4 as resuspension buffer (Kout < Kin
resuspension buffer) and 250 mM sucrose, 0.1 mM Ca(gluconate)2,
2.5 mM Mg(gluconate)2, 20 mM Hepes/Tris, pH 7.4 as incubation
buffer (Kout < Kin incubation buffer).
2.5.1.2. ATP dependent uptake studies. For ATP dependent uptake
studies, vesicles were resuspended in 50 mM sucrose, 100 mM
KNO3, 20 mM Hepes/Tris pH 7.4. The substrate containing
incubation buffer either consisted of 50 mM sucrose, 100 mM
KNO3, 12.5 mM Mg(NO3)2, 10 mM Hepes/Tris, pH 7.4 alone or with
6.25 mM ATP. Uptake was performed as described in 2.5.1.
2.5.1.3. Detaching of ribosomes from RER vesicles. Attached ribo-
somes of RER vesicles were removed using puromycin and high KCl
concentration as described previously [33]. SER vesicles were
treated in parallel as control. Brieﬂy, vesicles were treated in
Kout > Kin resuspension buffer as described in 2.5.1.1. or 0.25 M
sucrose, 0.75 M KCl, 1 mM puromycin, 50 mM Tris/HCl pH 7.4 for
1 h at room temperature. After centrifugation (15 min, 103 856 g)
SER and ribosome-free RER vesicles were resuspended in Kout > Kin
resuspension buffer. Protein of SER and RER vesicles was
determined using bicinchoninic acid (Thermo Scientiﬁc, Waltham,
Massachusetts) and bovine serum albumin as standard and uptake
of TC was measured at an inward positive membrane potential as
described in section 2.5.1 and 2.5.1.1.
2.5.1.4. Na+-dependent taurocholate uptake. For sodium dependent
TC transport, vesicles were resuspended in 250 mM sucrose,
0.1 mM Ca(gluconate)2, 20 mM Hepes/Tris, pH 7.4. The substrate
containing incubation buffer consisted of 50 mM sucrose, 0.1 mM
Ca(gluconate)2, 2.5 mM Mg(gluconate)2, 20 mM Hepes/Tris pH 7.4
and either 100 mM NaCl or KCl. Uptake studies were performed as
described in section 2.5.1.
2.5.1.5. Osmolarity plots. Experiments for generating osmolarity
plots were performed at an inward positive membrane potential at
an incubation time point of 10 min (see section 2.5.1.1.) [34].
Vesicles were resuspended in Kout > Kin resuspension buffer
(see 2.5.1.1.) and the osmolarity outside of the vesicles was
increased by adding increasing sucrose concentrations, ranging
from 50 mM to 800 mM, to the Kout > Kin incubation buffer (see
2.5.1.1.). Uptake was performed as described in section 2.5.1.
Uptake (pmol/mg protein) was plotted against the reciprocal
osmolarity of the incubation buffer and linear regression analyses
were performed using the GraphPad prism software (GraphPad
Software Inc., San Diego, USA). The amount of substrate binding to
vesicles is given at the intercept of the extrapolated linear
regression with the y-axis (uptake), whereas uptake rates observed
at identical intra- and extravesicular osmolarities corresponding to
250 mM sucrose was taken as 100%.
2.5.2. Vesicle efﬂux studies
For efﬂux studies, 100 mg vesicles were preincubated with the
givenconcentrationofradiolabelledsubstrate inresuspensionbuffer
in parallel with valinomycin treatment (see section 2.5.1.1). Efﬂux
was initiated by a 60- fold dilution with incubation buffer. After the
desiredtimeofincubationat37 8C,efﬂuxwasstoppedbytheaddition
of ice-cold stop solution and vesicle associated radioactivity was
measured as described in 2.5.1 Membrane potentials during efﬂux
studies were generated as described before (section 2.5.1.1).
2.6. High performance thin layer chromatography (HPTLC) analysis
As described previously [22] 20 ml (3.5 mg/ml protein) vesicles
were preincubated at 37 8C and mixed with 80 ml of E3S containing
Fig. 1. Western blot analysis of Cyp3a2, Sec61a, Oatp1a1, Ntcp, Mrp2, and PDI in SER and RER isolated from Wistar and TR rat livers.
5 mg (Cyp3a2, Mrp2), 50 mg (Sec61a) or 100 mg (Oatp1a1, Ntcp) protein was loaded per lane and separated by SDS-PAGE as given in section 2.4. Samples were probed against
Cyp3a2, Sec61a, Oatp1a1, Ntcp, Mrp2, and PDI as described in 2.4. PDI was used as loading control in SER and RER fractions. Basolateral membrane fraction (BLM) isolated
from Sprague Dawley rat liver was used as positive control for Oatp1a1 and Ntcp expression. Canalicular (CM) membrane fraction isolated from Sprague Dawley rat liver was
used as positive control for Mrp2 expression. The ﬁgure shows a representative Western blot of at least two independent SER and RER isolations.
Table 1
Cyp3a2 and Sec61a expression normalized to PDI expression.
Rat strain Fraction Cyp3a2/PDI ratio Sec61a/PDI ratio
Wistar SER 1.60 1.99
RER 0.86 0
TR SER 0.38 2.49
RER 0.023 0
Data shown in the table represent the mean ratio of the areas measured by
densitometry for Cyp3a2, Sec61a and PDI expression of two independent vesicle
preparations, including the one shown in Fig. 1.
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mixture was incubated for the desired time period at 37 8C at a
thermoshaker (900 rpm) and reaction was stopped by the addition
of 100 ml ice cold ethanol. The samples were centrifuged at 20
200 g (14 000 rpm) for 10 min at 4 8C and 25 ml of the supernatant
were loaded on HPTLC Silicagel 60 plates (Merck, Darmstadt,
Germany) using an automated TLC sampler (Camag, ATS4,
Muttenz, Switzerland). Chromatography was performed using a
solvent mixture of ethyl acetate:methanol:25% ammoniumhydr-
oxide solution at a volume ratio of 37.5:12.5:1. The developing
chamber was saturated with the same solvent mixture from
10 min prior to development of the HPTLC plate. The HPTLC plate
was developed until the solvent front reached 8 cm from the
bottom of the plate (15 min). The plate was dried at 100 8C for
10 min and a X-ray ﬁlm (Fujiﬁlm, Dielsdorf, Switzerland) was
exposed for 9 days to 1 month.
2.7. Statistical analysis
Data are given as means  SD. The number of independent
experiments is given in the ﬁgure and table legends.
Where indicated, statistical signiﬁcance was calculated using
unpaired t-test and the GraphPad prism software (GraphPad
Software Inc., San Diego, USA). A p-value <0.05 was considered as
statistical signiﬁcant.
3. Results
3.1. Characterization of SER and RER vesicles
To test for successful separation of SER and RER, expression of
proteins known to be present in different ER compartments
(Cyp3a2, Sec61a and the protein disulﬁd isomerase PDI), was
analyzed by Western blotting.While PDI is reported to be equally distributed between SER and
RER [35], Sec61a is enriched in the RER [35] and Cyp3a2 in the SER
[8]. These markers were routinely assessed in the isolated SER and
RER fractions. In our ER subfractions, PDI showed, as published,
similar expression levels in SER and RER and was therefore chosen
as loading control (Fig. 1). Sec61a expression was indeed restricted
to the RER fractions and Cyp3a2 expression was detected at
considerably higher levels in SER as compared to the RER fractions
but did not reach statistical signiﬁcance in densitometric
measurements (Table 1). Hence, we successfully isolated mem-
brane fractions enriched in RER or in SER. Interestingly, TR rats
showed decreased Cyp3a2 expression compared to Wistar rats,
which is in accordance to previous data [36], while Sec61a was
expressed at similar levels in both rat strains (Fig. 1, Table 1).
To assess potential cross-contamination of isolated vesicles
with plasma membranes, protein expression of basolateral and
canalicular membrane proteins, including Ntcp, Oatp1a1 and
Mrp2, was also tested by Western blotting. In comparison to
basolateral or canalicular membrane fractions of Male Sprague
Dawley rats, used as positive controls, expression of all three
proteins was only faint. Therefore, contamination of RER and SER
fractions with plasma membrane is only marginal (Fig. 1).
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3.2.1. Taurocholate uptake
Uptake of taurocholate (TC) into SER and RER vesicles was time-
dependent and electrogenic (Fig. 2A and 2B), showing 1.8 to 2.6
higher transport rates at an inward positive membrane potential
compared to an inward negative membrane potential generated by
potassium gradients and valinomycin treatment at 30 sec of
incubation (Fig. 2B). Hence, the isolated SER and RER vesicles are
transport competent and display electrogenic TC uptake, as
previously demonstrated for rat liver microsomes [25]. Additionally,
TC uptake showed an overshoot phenomenon, with an about 1.2 fold
higher uptake at 30 sec compared of uptake rates observed after 1 h
in SER and RER isolated from Wistar and TR rat liver (Fig. 2A).
Comparing TC uptake rates in SER and RER vesicles, TC uptake
was about 1.5 fold higher in SER than in RER vesicles in Wistar rats
at an incubation time of 30 sec. Also TR rats showed a 2.5 fold
higher TC uptake at this time point of incubation into SER
compared to RER vesicles (Fig. 2A). As RER vesicles can have aFig. 2. TC uptake (A, B, C) and efﬂux (D) in SER and RER of Wistar and TR rat liver.
A: Uptake of 1 mM TC was determined in SER and RER fractions after different time poin
section 2.5.1. Data are shown for a representative sample of 3 independent experiments w
in triplicates.
B: Uptake of 1 mM TC was determined in SER and RER fractions after 30 sec of incubation at a
Data are shown for a representative sample of 3 independent experiments where uptake is
Statistically signiﬁcant difference in TC uptake between an inward positive and negative m
p < 0.001.
C: Uptake of 1 mM TC was determined in SER, RER fractions and basolateral membrane (BLM
section 2.5.1.4. Data are shown for a representative sample of 2 independent experiments. D
sodium. Values are given as means  SD from measurements at least in triplicates. Statistica
vesicles are indicated by asterisks as followed: * for p < 0.05 and ** for p < 0.01.
D: Efﬂux of TC out of SER and RER vesicles preloaded with 1 mM TC was measured at an i
(mean  SD from measurements in triplicates) are shown for a representative sample of 2higher protein content due to the attached ribosomes than SER
vesicles, SER and RER vesicles were treated with puromycin and
KCl (see section 2.5.1.3.) to strip off attached ribosomes. Even after
removal of ribosomes from RER vesicles, uptake of TC into SER
vesicles was 2.7 fold higher than into RER vesicles (data not
shown).
To exclude that the observed TC transport is due to
contamination by basolateral membranes, sodium-dependent
Ntcp-mediated TC uptake was measured (Fig. 2C). Basolateral
membrane vesicles, which were used as positive control for Ntcp-
mediated sodium-dependent TC transport, showed only 35%
sodium independent of total TC transport. Contrary, 67-83% of
total TC transport was sodium independent in SER and RER vesicles
isolated from Wistar and TR rat livers. Consequently, only a
marginal sodium-dependent (Ntcp-mediated) transport activity
for TC was shown in SER and RER fractions compared to basolateral
membrane fractions, supporting minimal expression of these
proteins observed by Western blotting (Fig. 1) and consequently
attributing the electrogenic TC transport activity to SER and RER.ts of incubation at 37 8C at an inward positive membrane potential as described in
here uptake is calculated as mean pmol/mg protein  SD from measurements at least
n inward positive (+) or negative (-) membrane potential as described in section 2.5.1.1.
 calculated as mean pmol/mg protein  SD from measurements at least in triplicates.
embrane potential are indicated by asterisks as followed: ** for p < 0.01 and *** for
) after 30 sec of incubation at 37 8C in presence and absence of sodium as described in
ata show TC uptake in absence of sodium given as % of uptake measured in presence of
lly signiﬁcant difference in TC uptake between ER fractions and basolateral membrane
nward positive membrane at 30 sec of incubation at 37 8C as described in 2.5.2. Data
 independent experiments.
Fig. 3. Osmolarity plot for TC (A) and E17bG (B) in SER of Wistar rat liver.
Uptake of TC (1 mM) or E17bG (5 mM) was measured after an incubation time of 10 min at 37 8C at an inward positive membrane potential as described in 2.5.1.5. Outside
osmolarity (Osm) was increased by adding sucrose ranging from 50 to 800 mM. Data (mean  SD and linear regression analysis) are shown for a representative sample of 2
independent experiments.
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rat strains showed comparable uptake characteristics for TC
(Fig. 2).
3.2.2. Taurocholate efﬂux
As found for TC uptake, efﬂux of this compound out of SER and
RER vesicles isolated from Wistar and TR rat liver was also time-
dependent, indicating bidirectional transport of TC across the ER
membrane (Fig. 2D). Within 30 sec of incubation about 70-80% of
TC was transported out of SER and RER vesicles. Again, differences
in TC efﬂux between Wistar and TR rats were only minimal.
3.2.3. Taurocholate transport versus binding
To discriminate between intravesicular uptake and unspeciﬁc
binding of the substrate to the vesicle membrane, osmolarity plots
were performed. As shown in Fig. 3A, osmolarity plot for TCFig. 4. Time-dependent uptake (A) and efﬂux (B) of E17bG in SER and RER of Wistar a
A: Uptake of 5 mM E17bG was determined in SER and RER fractions after different time po
2.5.1. Data are shown for a representative sample of 3 independent experiments where
triplicates.
B: Effux of E17bG out of E17bG (5 mM) preloaded vesicles was measured at an inward posi
(mean  SD from measurements in triplicates) are shown for a representative sample of 2demonstrated a slope signiﬁcantly different from zero. Conse-
quently, active transport for TC can be assumed. However, 53%
vesicle associated TC accounted for binding to membranes.
3.3. Estradiol-17b-glucuronide transport
3.3.1. Estradiol-17b-glucuronide uptake and efﬂux
For E17bG a fast initial uptake within the ﬁrst 10 sec of
incubation was found (Fig. 4A). No change in uptake rates with
increasing incubation time was seen between 10 sec and 1 min.
Nevertheless, at equilibrium (after 1 h), E17bG uptake was 1.6 to
1.9 fold higher as compared to the uptake rates observed at an
incubation time of 10 sec (Fig. 4A). The presence of ATP did not
increase E17bG uptake rates (Table 2), indicating the absence of a
functional Mrp in this membrane preparation and conﬁrming data
of Western blot analysis (Fig. 1).nd TR rat liver.
ints of incubation at 37 8C at an inward positive membrane potential as described in
 uptake is calculated as mean pmol/mg protein  SD from measurements at least in
tive membrane potential after different time points at 37 8C as described in 2.5.2. Data
 independent experiments.
Table 2
E17bG uptake in absence and presence of ATP in Wistar SER and RER fractions.
Incubation time SER RER
-ATP + ATP -ATP + ATP
pmol/mg protein pmol/mg protein % of -ATP pmol/mg protein pmol/mg protein % of -ATP
15sec 129  7 116  22 90  17 136  9 108  9 80  6
1 min 138  17 159  18 115  13 132  5 135  8 102  6
5 min 181  20 188  13 104  7 173  14 161  14 93  8
2 h 270  20 265  8 98  3 207  11 223  11 108  5
Data of E17bG uptake in absence and presence of ATP at the given time points of incubation are shown for a representative sample of 2 independent experiments using
vesicles from different vesicle preparations. Data are given as mean pmol/mg protein  SD from measurements at least in triplicates.
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A fast efﬂux of E17bG could be detected in both microsomal
fractions of Wistar and TR rat livers (Fig. 4B), showing export of
42-47% of E17bG already after 5 sec of incubation. Efﬂux of E17bG
increased with time and after 30 sec 66-73% of preloaded E17bG
were released. At 1 h of incubation only 16-20% of the substrates
were left in the vesicles. Similar efﬂux rates were observed in SERFig. 5. Uptake (A, B) and osmolarity blot (C) of E3S.
A: Time-dependent uptake of 5 mM E3S was determined in SER and RER fractions of Wi
positive membrane potential as described in 2.5.1. Uptake is calculated as mean pmo
representative sample of 2 independent experiments.
B: Uptake of 5 mM E3S was determined in SER and RER fractions of Wistar and TR rat liver a
described in section 2.5.1.1. Data are shown for a representative sample of 2 independ
measurements in triplicates. Statistically signiﬁcant difference in TC uptake between an inw
for p < 0.05 and ** for p < 0.01.
C: Uptake of E3S (5 mM) was measured in SER of Wistar rat liver after an incubation time of 10
osmolarity (Osm) was increased by adding sucrose ranging from 50 to 800 mM. Data (m
independent experiments.and RER. Wistar and TR rats showed comparable characteristics of
E17bG efﬂux.
3.3.3. Estradiol-17b-glucuronide transport versus binding
Osmolarity plots for E17bG were performed to discriminate
between intravesicular uptake and unspeciﬁc binding. A slope
signiﬁcantly different from zero was shown (Fig. 3B), demonstratingstar and TR rat liver after different time points of incubation at 37 8C at an inward
l/mg protein  SD from measurements at least in triplicates. Data are shown for a
fter 10 sec of incubation at an inward positive (+) or negative (-) membrane potential as
ent experiments where uptake is calculated as mean pmol/mg protein  SD from
ard positive and negative membrane potential are indicated by asterisks as followed: *
 min at 37 8C at an inward positive membrane potential as described in 2.5.1.5. Outside
ean  SD and linear regression analysis) are shown for a representative sample of 2
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E17bG account for membrane binding.
3.4. Estrone-3-sulfate transport
3.4.1. Estrone-3-sulfate uptake
The transport of estrone-3-sulfate (E3S) in SER and RER vesicles
isolated from Wistar and TR rat liver was time-dependent. A fast
increase of E3S uptake was detected within the ﬁrst 2 min of
incubation in SER and RER vesicles, (Fig. 5A) remaining nearly
constant between 5 and 10 min of incubation. At equilibrium after
1 h of incubation E3S uptake rates slightly decreased to 82-89% of
levels observed at 10 min of incubation (Fig. 5A). Higher E3S
uptake rates were detected at an inward positive membrane
potential compared to an inward negative membrane potential,
showing a 2.5- and 1.9 fold increase in SER membrane vesicles
isolated from Wistar and TR rat livers, respectively after 10 sec of
incubation (Fig. 5B). Consequently, an inwardly directed positive
membrane potential was chosen for further transport experi-
ments.
As observed for TC, E3S showed higher uptake rates in SER
compared to RER membrane fractions. In Wistar rats, E3S uptake
was 6.8 fold higher in SER than in RER at 15 sec of incubation
(Fig. 5A). Likewise, in SER isolated from TR rats a 2.5 fold
increase of E3S uptake compared to the RER fraction was observed
(Fig. 5A).Fig. 6. Autoradiogram (A-D) and time-dependent uptake (E) of E3S in presence (B, D, E
A-D: Wi SER (A, B) and RER (C, D), either not preincubated (A, C) or preincubated with 1 
5 mM E3S and processed as described in section 2.6. After chromatography, X-ray ﬁlm
E: Uptake of 5 mM E3S was determined in SER and RER fractions either without (light g
incubation at 37 8C at an inward positive membrane potential as described in 2.5.1. Da
calculated as mean pmol/mg protein  SD from measurements at least in triplicates.Similar to TC transport, Wistar and TR rats showed comparable
transport characteristics for E3S.
3.4.2. Estrone-3-sulfate transport versus binding
In contrast to TC and E17bG, E3S osmolarity plots showed no
transport into an osmotically active space, suggesting binding of
the substrate to or partioning into the vesicle membranes (Fig. 5C).
3.4.3. Role of steroidsulfatase in estrone-3-sulfate transport
As E3S uptake into SER and RER vesicles was time-dependent,
but showed 100% binding to vesicle membranes, high performance
thin layer chromatography (HPTLC) analyses were performed to
investigate the chemical intactness of the substrate at the end of
the uptake studies.
HPTLC analysis showed time-dependent E3S hydrolysis in SER
(Fig. 6A) as well as in RER (Fig. 6C) vesicles. At 15 sec of incubation
92% and 94% of the substrate was still intact in RER and SER
vesicles, respectively. Only 18% and 42% of E3S was not hydrolyzed
after 2 min in SER and RER vesicles, respectively, indicating slightly
slower E3S hydrolysis in RER as compared to SER. Complete
degradation in both ER fractions was observed after 10 min. Hence,
the binding of the estrone, which carries the radioactive label may
indeed be partitioning into the membrane of the vesicles used for
the transport studies. As the catalytic site of steroidsulfatase (STS)
is located within the ER lumen, vesicles were preincubated with
the irreversible STS inhibitor Stx64 for 30 min at room temperature) and absence (A, C, E) of the STS inhibitor Stx64.
mM Stx64 (B, D), were incubated for 0, 15 sec, 30 sec, 2 min, 5 min and 10 min with
 was exposed for 1 month. S, incubation buffer containing 5 mM E3S as standard.
rey) or with (dark grey) Stx64 (1 mM) preincubation after different time points of
ta are shown for a representative sample of 2 independent experiments. Uptake is
Table 3
Summary of cis-inhibition studies of TC uptake at an incubation time of 30 sec.
Inhibitor (conc.) SER RER
Control + Inhibitor Control + Inhibitor
pmol/mg protein pmol/mg protein % of control pmol/mg protein pmol/mg protein % of control
E17bG (100 mM) 37 W 2 20 W 1*** 53 W 3 18 W 3 13 W 2* 71 W 3
E3S (100 mM) 33 W 5 20 W 4* 60 W 5 17  4 12  3 71  5
UDPGA (4 mM) 38  2 36  5 94  8 17  3 15  3 88  3
Stx64 (1 mM) 38  3 34  5 90  7 18  2 17  4 94  12
G6P (1 mM) 36  3 32  1 90  5 23  5 21  5 88  7
Vanadate (1 mM) 36  3 33  1 93  5 23  5 21  4 92  5
Vanadate (1 mM) G6P (1 mM) 36  3 32  2 90  5 23  5 20  4 87  9
Data of TC uptake in absence (Control) and presence (+ Inhibitors) of the given inhibitors are given as mean pmol/mg protein  SD of at least 3 independent experiments using
vesicles from different vesicle preparations. Statistically signiﬁcant difference in uptake rates compared to the control is given in bold. P-values are indicated by asterisks as
followed: * for p < 0.05 and *** for p < 0.001.
K. Wlcek et al. / Biochemical Pharmacology 88 (2014) 106–118114followed by 30 min incubation on ice prior to HPTLC analyses.
Indeed, E3S was prevented from hydrolysis at any time point of
incubation in SER and RER (Fig. 6B and D).
The effect of STS inhibition on E3S uptake was therefore also
studied in SER and RER vesicles either pretreated or not pretreated
with Stx64. Similar to the time-dependent hydrolysis, E3S uptake
decreased with time in Stx64 treated vesicles (Fig. 6E) reaching a
maximal inhibitory effect after 5 min of incubation.
3.5. Inhibition studies
To compare functional characteristics of TC, E3S and E17bG
transport in more detail, inhibition studies were performed.
Furthermore, a possible involvement of already identiﬁed ER
transporters, including the glucose-6-phosphate transporter [37–
39] and the UDPGA transporter [40–42], in TC, E3S, and E17bG
transport was investigated. Therefore, UDPGA and glucose-6-
phosphate (G6P) were included in inhibition experiments. In case
of inhibition studies with G6P, vanadate treatment of vesicles was
included to inhibit the glucose-6-phosphatase [43]. A control
experiment without vanadate treated vesicles was also performed.
3.5.1. Cis- inhibition studies on TC transport
As shown in Table 3, TC transport was inhibited by both
estrogens, E3S and E17bG, at an incubation time of 30 sec. E17bG
signiﬁcantly decreased TC uptake in SER and RER vesicles to 53%
and 71% of the control respectively. E3S also showed a signiﬁcant
inhibitory effect on the uptake of TC, reducing uptake rates to 60%
of the control in SER vesicles. Although TC transport was also
reduced to 71% of the control in RER vesicles, inhibition did not
reach statistical signiﬁcance.
As Stx64 was shown to inhibit E3S uptake, its effect on TC
uptake was also studied, but no effect could be observed. Likewise,Table 4
Summary of cis-inhibition studies of E3S uptake at an incubation time of 15 sec.
Inhibitor (conc.) SER 
Control + Inhibitor 
pmol/mg protein pmol/mg protein 
E17bG (100 mM) 303 W 52 220 W 43* 
TC (50 mM) 303  52 261  66 
UDPGA (4 mM) 281  35 284  41 
Stx64 (1 mM) 319  45 253  26 
G6P (1 mM) 259  62 256  69 
Vanadate (1 mM) 259 W 62 129 W 29** 
Vanadate (1 mM) G6P (1 mM) 259 W 62 137 W 27** 
Data of E3S transport in absence (Control) and presence (+ Inhibitors) of the given inhib
using vesicles from different vesicle preparations. Statistically signiﬁcant difference in upta
followed: * for p < 0.05; and ** for p < 0.01.neither UDPGA nor G6P (with or without vanadate treatment)
affected TC uptake in SER and RER vesicles.
3.5.2. Cis- inhibition studies on E3S transport
Table 4 shows the results of inhibition studies for E3S uptake at
an incubation time of 15 sec. E3S uptake was signiﬁcantly inhibited
by E17bG in SER, showing a decrease to 73% of the control.
Although the E3S uptake into RER was reduced to 62% in presence
of E17bG, this inhibitory effect was not statistically signiﬁcant. TC
did not affect E3S uptake, neither in SER nor in RER fractions.
E3S uptake was also signiﬁcantly inhibited in vanadate treated
vesicles to 54-57% of control in SER. In RER the inhibitory effect was
even more pronounced and E3S uptake was almost completely
inhibited. The irreversible STS inhibitor Stx64 decreased E3S
transport to 80% and 76% in SER and RER fractions respectively, but
did not reach statistical signiﬁcance. No inhibitory effect was
observed for UDPGA and G6P.
3.5.3. Trans- inhibition studies on E17bG efﬂux
For E17bG efﬂux, trans-inhibition studies were performed at an
incubation time of 5 sec. As shown in Table 5, E3S signiﬁcantly
inhibited E17bG efﬂux out of SER and RER vesicles. Compared to
controls, E17bG efﬂux was inhibited by 59% in SER. In RER the
inhibitory effect reduced E17bG efﬂux to 66% compared to the
control, which did not reach statistical signiﬁcance.
Neither TC, nor one of the other tested compounds, including
UDPGA, Stx64 or G6P (with or without vanadate) affected E17bG
efﬂux.
4. Discussion
The extensive network of the ER accounts for more than 50% of
the total membrane surface and about 15% of the total volume inRER
Control + Inhibitor
% of control pmol/mg protein pmol/mg protein % of control
73 W 7 136  73 90  56 62  10
86  12 136  73 113  58 95  41
101  6 146  17 156  27 106  6
80  6 154  23 120  54 76  26
99  5 94  43 92  33 103  18
54 W 25 94 W 43 4 W 6* 4 W 4
57 W 26 94 W 43 11 W 14* 12 W 11
itors are given as mean pmol/mg protein  SD of at least 3 independent experiments
ke rates compared to the control is given in bold. P-values are indicated by asterisks as
Table 5
Summary of trans-inhibition studies of E17bG efﬂux at an incubation time of 5 sec.
Inhibitor (conc.) SER RER
Control + Inhibitor Control + Inhibitor
pmol/mg protein/5sec pmol/mg protein/5sec % of control pmol/mg protein/5sec pmol/mg protein/5sec % of control
E3S (100 mM) 22 W 2 9 W 5* 41 W 19 19  4 13  2 66  6
TC (50 mM) 19  2 21  5 108  16 18  3 21  6 115  18
UDPGA (4 mM) 18  1 20  3 111  20 18  4 19  6 103  14
Stx64 (1 mM) 21  1 19  3 91  16 21  5 20  5 96  9
G6P (1 mM) 20  4 20  5 99  11 20  1 21  2 105  3
Vanadate (1 mM) 20  4 24  3 118  11 20  1 20  3 105  14
Vanadate (1 mM) G6P (1 mM) 20  4 24  3 118  11 20  1 21  5 104  16
Data of E17bG efﬂux in absence (Control) and presence (+ Inhibitors) of the given inhibitors are given as mean pmol/mg protein/5 sec transported out of the vesicles  SD of at
least 3 independent experiments using vesicles from different vesicle preparations. Statistically signiﬁcant difference in efﬂux rates compared to the control is given in bold. P-
values are indicated by asterisks as followed: * for p < 0.05.
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mation reactions, including UGTs [16] and the STS [10–12]. As both
enzymes [12,19] have their catalytic sites within the ER lumen,
their substrates, co-substrates as well as end products have to
cross the ER membrane. Based on their physicochemical properties
these compounds are not favored for passive diffusion and
necessitate transport systems.
Therefore we investigated the transport of the STS model
substrate E3S and the typical UGT generated E17bG across the
membrane of the smooth (SER) and the rough (RER) ER
subcompartment isolated from rat liver. Successful separation of
SER and RER vesicles isolated as well as only marginal contamina-
tion of SER and RER with plasma membrane was shown by
Western blot analysis. Electrogenic TC uptake, shown in the
present study, is in accordance to previous data [25] and therefore
conﬁrms the functionality of the vesicles used in our study. In
addition, we demonstrated bidirectional TC transport across SER
and RER, with higher uptake rates in SER compared to RER. For
E17bG, a fast efﬂux out of SER and RER vesicles was shown, while
no clear protein-mediated uptake was observed for this com-
pound. Contrary, E3S uptake increased with time in SER and RER
vesicles. Likewise similar time-dependency was observed in STS
mediated E3S hydrolysis. For all three studied substrates, uptake
characteristics only minimally differ between wild-type and the
mutant TR rats, which lack of the efﬂux pump Mrp2.
Electrogenic TC uptake with higher uptake rates at an
intravesicular positive K+ diffusion potential has previously been
reported in total microsomes, in ER enriched microsomes [25] as
well as in SER vesicles [45] isolated from rat liver. Hence, we used
in the present study TC transport as a positive control. TC transport
into SER has been suggested to be accomplished by the microsomal
enzyme epoxide hydrolase based on experiments with immuno-
precipitation and reconstitution in proteoliposomes [45]. Howev-
er, no differences in bile salt uptake into wild-type BHK-21 cells
and rat epoxide hydrolase transfected BHK-21 cells were later
found, indicating that this enzyme is unlikely responsible for TC
transport across the plasma membrane [46] and consequently also
not into SER. In rodents, TC uptake into hepatocytes is mediated by
Oatp1a1, Oatp1a4, and Oatp1b2 located at the basolateral
membrane [47]. Oatp1a1 and Oatp1a4 expressing Xenopus laevis
oocytes showed bidirectional TC transport [48]. Additionally, TC
transport via Oatp1a1 was not affected by a K+ diffusion membrane
potential in Xenopus laevis oocytes [49]. Contrary, our observations
showed higher TC transport rates into SER and RER vesicles at an
inwardly directed K+ gradient. Besides Oatps, the major part of TC
uptake in hepatocytes is mediated by the Na+- taurocholate co-
transporting polypeptide (Ntcp) in a sodium-dependent manner
[50]. However, in our study sodium dependent uptake of TC
accounted for only 20-30% of total TC uptake, which is much less
than in isolated basolateral plasma membrane vesicles [51]. Basedon TC transport characteristic shown in our study and a lack of
signiﬁcant amounts of Oatp1a1 and Ntcp protein in our SER and
RER preparations, these TC transporters seem not to be involved in
TC transport across SER and RER membranes. At present, the
physiologic role of possible taurocholate transport into the ER is
not fully understood. While glucuronidation of bile acids has been
reported to be mediated by UGT1A3 [52], this pathway is under
most situations minor in hepatocellular bile salt homeostasis [53].
Under prolonged cholestasis, glucuronidation of bile acids may act
as an alternative biotransformation pathway for ameliorating the
cytotoxicity of bile acids [54]. Whether glucuronidated bile salts
leave the lumen of the ER by the same transport systems as the one
described here remains to be elucidated.
UGT mediated glucuronidation takes place within the ER lumen
[19] and requires the exit of the reaction products back to the
cytoplasm. This transport pathway has been investigated for
different glucuronides, including 4-methylumbelliferyl-b-D-glu-
curonide [24], phenolphthalein-b-D-glucuronide [23], naphthol
AS-BI glucuronide [23], morphine-3-glucuronide [23,55] and
E17bG [22] using total rat liver microsomes. Glucuronide uptake
increased with time in these studies and in accordance to our
observations fast initial uptake rates were observed for E17bG
[22], 4-methylumbelliferyl-b-D-glucuronide [24], phenolphtha-
lein-b-D-glucuronide and naphthol AS-BI glucuronide [23]. After
the fast initial uptake phase, E17bG content was nearly constant
over a time period of 20 sec to 1 min followed by a slow increase up
to 1 h of incubation in our study. Such a biphasic uptake rate could
be explained by a trans-inhibition of the transported substrate.
Published data reported that a steady state level is reached after
the initial uptake phase and was unchanged for at least 40 min or
60 min for E17bG [22] or phenolphthalein-b-D-glucuronide [23]
respectively. This difference could be due to different isolation
procedures of the membrane vesicles investigated. As we have
shown here for E17bG in SER and RER, efﬂux of phenolphthalein-
b-D-glucuronide [23], morphine-3-glucuronide [55] and E17bG
[22] was also fast and time-dependent out of total rat liver
microsomes. Comparing time-dependent uptake and efﬂux of
different glucuronides, morphine-3-glucuronide [23,55] showed
slower uptake and efﬂux rates as compared to 4-methylumbelli-
feryl-b-D-glucuronide [24], phenolphthalein-b-D-glucuronide
[23] and E17bG [22], indicating the existence of different transport
systems for the transport of glucuronides of different molecular
weight and consequently size across the ER membrane [23]. An
effect of molecular weight on glucuronide efﬂux has also been
indicated for bilirubin glucuronide and 1-naphthol glucuronide in
human liver microsomes [56]. To our knowledge the transport
system(s) responsible for glucuronide transport across the ER
membrane has not been identiﬁed at the molecular level so far. An
antiport with the UGT co-substrate UDPGA has been postulated, as
extravesicular UDPGA stimulated the efﬂux of p-nitrophenol- and
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somes (trans-stimulation) [21]. UGTrel7 (SLC35D1) has been
identiﬁed as UDPGA transporter [40–42] and therefore could be
involved in the UDPGA/glucuronide antiport process. As we did not
observe any effect of UDPGA on E17bG efﬂux in trans-inhibition
studies, neither an antiport with UDPGA nor an involvement of the
UDPGA transporter in E17bG efﬂux can be suggested from the
present study. This is also in accordance to previous cis-inhibition
studies showing that extravesicular UDPGA had no effect on the
uptake of E17bG [22]. The clear and fast efﬂux of E17bG out of ER
vesicles and the observed slow, biphasic uptake indicate an
asymmetric transport system for this compound across the ER
membrane, which preferentially export E17bG out of vesicles. As
evidence is given for the existence of different transport systems
for glucuronides of different molecular weights, substrate speci-
ﬁcity of such an asymmetric efﬂux transporter has to be further
evaluated.
After glucuronidation and translocation of formed glucuronides
from the ER lumen back into the cytoplasm, glucuronides have to
be excreted out of hepatocytes. At the canalicular membrane, the
ATP binding cassette transporter Mrp2 is responsible for the ATP
dependent export of glucuronides into the bile [5]. Recently, Mrp2
expression in the nuclear envelope, another subcompartment of
the ER besides SER and RER, has been demonstrated by Western
blotting in rat liver nuclear envelope fractions [57]. As we did not
ﬁnd an ATP dependent E17bG uptake in SER and RER vesicles,
which was also previously absent in total liver microsomes [22],
and Mrp2 expression was absent in our fractions an involvement of
Mrp2 in E17bG transport across the ER membrane seems unlikely.
Compared to TC and E17bG, no data are available studying the
transport of E3S across the ER membrane. Only one study
investigated the transport of NaSO4, showing a bidirectional
time-dependent but unsaturable transport in total microsomal
vesicles isolated from rat liver [58]. However, E3S hydrolysis
accomplished by STS within the ER lumen is the ﬁrst step in
estrogen synthesis [59] and hence requires E3S translocation from
the cytoplasm into the ER lumen. Although STS is known to beCYPs
T1
Vanadat e
Stx64
-SO4
E17 G
E
Fig. 7. Schematic overview of postulated transport systems (T1, T2, T3) for E17bG, E3S
Transport and inhibitory effect (?) of the different compounds are indicated by the diff
sulfate; TC, taurocholate; UDP-GA, UDP-glucuronic acid; CYPs, cytochrome P450s; UGTexpressed in placenta, STS activity and expression has also been
detected in rat and human liver [17,60,61]. E3S is a known
substrate of Oatps [47], which are therefore possible candidates for
E3S transport across the ER membrane. However, only low
expression of the basolateral rOatp1a1 was found in SER and
RER vesicles used in our study, indicating that Oatps are not likely
to be involved in E3S transport across in SER and RER vesicles.
Based on its structure, STS itself has been discussed to be involved
in E3S transport into the ER lumen. Two hydrophobic a-helices
anchor the STS in the ER membrane and are postulated to form a
tunnel which may allow the substrate to pass the ER membrane
and get access to the catalytic site of the enzyme [12]. This
suggestion is supported by our observations showing similarities
in the time-dependency of E3S uptake and E3S hydrolysis. We
demonstrated that in both, SER and RER fractions, E3S is
hydrolyzed with time reaching complete E3S hydrolysis after
10 min. Furthermore, we demonstrated inhibition of E3S uptake in
SER and RER vesicles by Stx64 and vanadate, which are both
described to inhibit STS activity [62,63]. Indeed, we conﬁrmed
inhibition of STS mediated E3S hydrolysis by Stx64 using high
performance thin layer chromatography. These results however do
not completely rule out a tight functional coupling between STS
and a yet unknown E3S transport system. An alternative
explanation for the observed decrease in E3S hydrolysis in the
presence of Stx64 could also be the reduced uptake of E3S due to
presence of this STS inhibitor. Our current data do not allow to
favor either of these possibilities.
In conclusion, our study showed clear differences in the
transport characteristics of TC, E3S, and E17bG across SER and
RER membrane vesicles. Furthermore, the two STS inhibitors Stx64
and vanadate caused inhibition of E3S uptake but did not affect TC
uptake or E17bG efﬂux. Therefore, we conclude that three different
transport systems (as illustrated in Fig. 7) are likely involved in the
transport of these compounds across the ER membrane. Our data
also indicate that neither the known ER transporters UGTrel7 [40–
42] and G6PT1 [37–39] nor the hepatocellular transporters Ntcp,
Oatp1a1 and Mrp2 seem to be involved in the translocation of TC,UDP
UDP-GA
E3S
SO4
TC
SO4
SO4
T3
, and TC in ER vesicles.
erent colors used. E, estradiol; E17bG, estradiol-17b-glucuronide; E3S, estrone-3-
s, UDP-glucuronosyltransferases, STS, steroidsulfatase.
K. Wlcek et al. / Biochemical Pharmacology 88 (2014) 106–118 117E3S, and E17bG across the ER membrane. Based on our Western
blot data, we conclude that the latter transporters are only found at
minimal levels and are therefore unlikely relevant for metabolite
transport processes in the ER.
Acknowledgements
K. Wlcek is supported by the Austrian Science Fund (FWF):
[J3136].
B. Stieger is supported by the Swiss National Science Founda-
tion [grant #31003A-124652], through the National Center of
Competence in Research (NCCR) TransCure (University of Berne,
Berne, Switzerland) and by the Center for Clinical Research,
University Hospital of Zurich and University of Zurich [grant #
DFL1227].
References
[1] Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. Interactions of
rifamycin SV and rifampicin with organic anion uptake systems of human
liver. Hepatology 2002;36:164–72.
[2] Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K, Tallman MN, Brouwer KL.
Integration of hepatic drug transporters and phase II metabolizing enzymes:
mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione
metabolites. Eur J Pharm Sci 2006;27:447–86.
[3] Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: their
role in drug metabolism and detoxiﬁcation. Int J Biochem Cell Biol 2013;
45:1121–32.
[4] Zollner G, Trauner M. Molecular mechanisms of cholestasis. Wien Med
Wochenschr 2006;156:380–5.
[5] Jedlitschky G, Leier I, Buchholz U, Hummel-Eisenbeiss J, Burchell B, Keppler D.
ATP-dependent transport of bilirubin glucuronides by the multidrug resis-
tance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J
1997;327(Pt 1):305–10.
[6] Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular
isoform of the MRP gene-encoded conjugate export pump from the hepato-
cytes in Dubin-Johnson syndrome. Hepatology 1996;23:1061–6.
[7] Jansen PL, Peters WH, Lamers WH. Hereditary chronic conjugated hyperbilir-
ubinemia in mutant rats caused by defective hepatic anion transport. Hepa-
tology 1985;5:573–9.
[8] Matsuura S, Fujii-Kuriyama Y, Tashiro Y. Immunoelectron microscope locali-
zation of cytochrome P-450 on microsomes and other membrane structures of
rat hepatocytes. J Cell Biol 1978;78:503–19.
[9] Radominska-Pandya A, Ouzzine M, Fournel-Gigleux S, Magdalou J. Structure of
UDP-glucuronosyltransferases in membranes. Methods Enzymol 2005;400:
116–47.
[10] Dibbelt L, Herzog V, Kuss E. Human placental sterylsulfatase: immunocyto-
chemical and biochemical localization. Biol Chem Hoppe Seyler 1989;
370:1093–102.
[11] Kawano J, Aikawa E. Ultrastructural localization of arylsulfatase C activity in
rat kidney. J Histochem Cytochem 1987;35:523–30.
[12] Hernandez-Guzman FG, Higashiyama T, Pangborn W, Osawa Y, Ghosh D.
Structure of human estrone sulfatase suggests functional roles of membrane
association. J Biol Chem 2003;278:22989–97.
[13] Voeltz GK, Rolls MM, Rapoport TA. Structural organization of the endoplasmic
reticulum. EMBO Rep 2002;3:944–50.
[14] Porter KR, Claude A, Fullam EF. A Study of Tissue Culture Cells by Electron
Microscopy: Methods and Preliminary Observations. J Exp Med 1945;81:233–
46.
[15] Ashley CA, Peters Jr T. Electron microscopic radioautographic detection of sites
of protein synthesis and migration in liver. J Cell Biol 1969;43:237–49.
[16] Chowdhury JR, Novikoff PM, Chowdhury NR, Novikoff AB. Distribution of
UDPglucuronosyltransferase in rat tissue. Proc Natl Acad Sci U S A 1985;
82:2990–4.
[17] Kawano J, Kotani T, Umeki K, Oinuma T, Ohtaki S, Aikawa E. A monoclonal
antibody to rat liver arylsulfatase C and its application in immunohistochem-
istry. J Histochem Cytochem 1989;37:683–90.
[18] Brown CA, Black SD. Membrane topology of mammalian cytochromes P-450
from liver endoplasmic reticulum. Determination by trypsinolysis of pheno-
barbital-treated microsomes. J Biol Chem 1989;264:4442–9.
[19] Vanstapel F, Blanckaert N. Topology and regulation of bilirubin UDP-glucur-
onyltransferase in sealed native microsomes from rat liver. Arch Biochem
Biophys 1988;263:216–25.
[20] Bossuyt X, Blanckaert N. Carrier-mediated transport of intact UDP-glucuronic
acid into the lumen of endoplasmic-reticulum-derived vesicles from rat liver.
Biochem J 1994;302(Pt 1):261–9.
[21] Banhegyi G, Braun L, Marcolongo P, Csala M, Fulceri R, Mandl J, et al. Evidence
for an UDP-glucuronic acid/phenol glucuronide antiport in rat liver micro-
somal vesicles. Biochem J 1996;315(Pt 1):171–6.[22] Battaglia E, Gollan J. A unique multifunctional transporter translocates estra-
diol-17beta -glucuronide in rat liver microsomal vesicles. J Biol Chem 2001;
276:23492–98.
[23] Csala M, Staines AG, Banhegyi G, Mandl J, Coughtrie MW, Burchell B. Evidence
for multiple glucuronide transporters in rat liver microsomes. Biochem Phar-
macol 2004;68:1353–62.
[24] Revesz K, Tutto A, Margittai E, Banhegyi G, Magyar JE, Mandl J, et al. Glucuro-
nide transport across the endoplasmic reticulum membrane is inhibited by
epigallocatechin gallate and other green tea polyphenols. Int J Biochem Cell
Biol 2007;39:922–30.
[25] Kast C, Stieger B, Winterhalter KH, Meier PJ. Hepatocellular transport of bile
acids. Evidence for distinct subcellular localizations of electrogenic and ATP-
dependent taurocholate transport in rat hepatocytes. J Biol Chem 1994;269:
5179–86.
[26] Meier PJ, Sztul ES, Reuben A, Boyer JL. Structural and functional polarity of
canalicular and basolateral plasma membrane vesicles isolated in high yield
from rat liver. J Cell Biol 1984;98:991–1000.
[27] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the
Folin phenol reagent. J Biol Chem 1951;193:265–75.
[28] Meier PJ, Spycher MA, Meyer UA. Isolation and characterization of rough
endoplasmic reticulum associated with mitochondria from normal rat liver.
Biochim Biophys Acta 1981;646:283–97.
[29] Eckhardt U, Schroeder A, Stieger B, Hochli M, Landmann L, Tynes R, et al.
Polyspeciﬁc substrate uptake by the hepatic organic anion transporter Oatp1
in stably transfected CHO cells. Am J Physiol 1999;276:G1037–42.
[30] Stieger B, Hagenbuch B, Landmann L, Hochli M, Schroeder A, Meier PJ. In situ
localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide
in rat liver. Gastroenterology 1994;107:1781–7.
[31] Madon J, Hagenbuch B, Landmann L, Meier PJ, Stieger B. Transport function
and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol 2000;
57:634–41.
[32] Boyer JL, Meier PJ. Characterizing mechanisms of hepatic bile acid transport
utilizing isolated membrane vesicles. Methods Enzymol 1990;192:517–33.
[33] Adelman MR, Blobel G, Sabatini DD. Nondestructive separation of rat liver
rough microsomes into ribosomal and membranous components. Methods
Enzymol 1974;31:201–15.
[34] Kessler M, Acuto O, Storelli C, Murer H, Muller M, Semenza G. A modiﬁed
procedure for the rapid preparation of efﬁciently transporting vesicles from
small intestinal brush border membranes. Their use in investigating some
properties of D-glucose and choline transport systems. Biochim Biophys Acta
1978;506:136–54.
[35] Gilchrist A, Au CE, Hiding J, Bell AW, Fernandez-Rodriguez J, Lesimple S, et al.
Quantitative proteomics analysis of the secretory pathway. Cell 2006;
127:1265–81.
[36] Jager W, Sartori M, Herzog W, Thalhammer T. Genistein metabolism in liver
microsomes of Wistar and mutant TR(-)-rats. Res Commun Mol Pathol Phar-
macol 1998;100:105–16.
[37] Gerin I, Veiga-da-Cunha M, Achouri Y, Collet JF, Van Schaftingen E. Sequence of
a putative glucose 6-phosphate translocase, mutated in glycogen storage
disease type Ib. FEBS Lett 1997;419:235–8.
[38] Marcolongo P, Fulceri R, Giunti R, Margittai E, Banhegyi G, Benedetti A. The
glucose-6-phosphate transport is not mediated by a glucose-6-phosphate/
phosphate exchange in liver microsomes. FEBS Lett 2012;586:3354–9.
[39] Senesi S, Marcolongo P, Kardon T, Bucci G, Sukhodub A, Burchell A, et al.
Immunodetection of the expression of microsomal proteins encoded by the
glucose 6-phosphate transporter gene. Biochem J 2005;389:57–62.
[40] Hiraoka S, Furuichi T, Nishimura G, Shibata S, Yanagishita M, Rimoin DL, et al.
Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate syn-
thesis in cartilage and skeletal development in mouse and human. Nat Med
2007;13:1363–7.
[41] Kobayashi T, Sleeman JE, Coughtrie MW, Burchell B. Molecular and functional
characterization of microsomal UDP-glucuronic acid uptake by members of
the nucleotide sugar transporter (NST) family. Biochem J 2006;400:281–9.
[42] Muraoka M, Kawakita M, Ishida N. Molecular characterization of human UDP-
glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide
sugar transporter with dual substrate speciﬁcity. FEBS Lett 2001;495:87–93.
[43] Singh J, Nordlie RC, Jorgenson RA. Vanadate: a potent inhibitor of multifunc-
tional glucose-6-phosphatase. Biochim Biophys Acta 1981;678:477–82.
[44] Weibel ER, Staubli W, Gnagi HR, Hess FA. Correlated morphometric and
biochemical studies on the liver cell. I. Morphometric model, stereologic
methods, and normal morphometric data for rat liver. J Cell Biol 1969;
42:68–91.
[45] Alves C, von Dippe P, Amoui M, Levy D. Bile acid transport into hepatocyte
smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide
hydrolase, a membrane protein exhibiting two distinct topological orienta-
tions. J Biol Chem 1993;268:20148–55.
[46] Honscha W, Platte HD, Oesch F, Friedberg T. Relationship between the micro-
somal epoxide hydrolase and the hepatocellular transport of bile acids and
xenobiotics. Biochem J 1995;311(Pt 3):975–9.
[47] Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/
SLC21 family: phylogenetic classiﬁcation as OATP/SLCO superfamily, new
nomenclature and molecular/functional properties. Pﬂugers Arch 2004;
447:653–65.
[48] Li L, Meier PJ, Ballatori N. Oatp2 mediates bidirectional organic solute
transport: a role for intracellular glutathione. Mol Pharmacol 2000;58:
335–40.
K. Wlcek et al. / Biochemical Pharmacology 88 (2014) 106–118118[49] Martinez-Becerra P, Briz O, Romero MR, Macias RI, Perez MJ, Sancho-Mateo C,
et al. Further characterization of the electrogenicity and pH sensitivity of the
human organic anion-transporting polypeptides OATP1B1 and OATP1B3. Mol
Pharmacol 2011;79:596–607.
[50] Stieger B. The role of the sodium-taurocholate cotransporting polypep-
tide (NTCP) and of the bile salt export pump (BSEP) in physiology
and pathophysiology of bile formation. Handb Exp Pharmacol 2011;
205–9.
[51] Zimmerli B, Valantinas J, Meier PJ. Multispeciﬁcity of Na + -dependent taur-
ocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesi-
cles. J Pharmacol Exp Ther 1989;250:301–8.
[52] Trottier J, Verreault M, Grepper S, Monte D, Belanger J, Kaeding J, et al. Human
UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxy-
cholic acid in the liver. Hepatology 2006;44:1158–70.
[53] Hofmann AF. Why bile acid glucuronidation is a minor pathway for conjuga-
tion of endogenous bile acids in man. Hepatology 2007;45:1083–4. author
reply 4-5.
[54] Frohling W, Stiehl A. Bile salt glucuronides: identiﬁcation and quantitative
analysis in the urine of patients with cholestasis. Eur J Clin Invest 1976;6:67–
74.
[55] Revesz K, Toth B, Staines AG, Coughtrie MW, Mandl J, Csala M. Luminal
accumulation of newly synthesized morphine-3-glucuronide in rat liver mi-
crosomal vesicles. Biofactors 2013;39:271–8.[56] Waddell ID, Robertson K, Burchell A, Hume R, Burchell B. Evidence for
glucuronide (small molecule) sorting by human hepatic endoplasmic reticu-
lum. Mol Membr Biol 1995;12:283–8.
[57] Rosales R, Monte MJ, Blazquez AG, Briz O, Marin JJ. ABCC2 is involved in the
hepatocyte perinuclear barrier for small organic compounds. Biochem Phar-
macol 2012;84:1651–9.
[58] Csala M, Senesi S, Banhegyi G, Mandl J, Benedetti A. Characterization of sulfate
transport in the hepatic endoplasmic reticulum. Arch Biochem Biophys
2005;440:173–80.
[59] Ghosh D. Human sulfatases: a structural perspective to catalysis. Cell Mol Life
Sci 2007;64:2013–22.
[60] Dolly JO, Dodgson KS, Rose FA. Studies on the oestrogen sulphatase and
arylsulphatase C activities of rat liver. Biochem J 1972;128:337–45.
[61] Selcer KW, Difrancesca HM, Chandra AB, Li PK. Immunohistochemical analysis
of steroid sulfatase in human tissues. J Steroid Biochem Mol Biol 2007;
105:115–23.
[62] Dibbelt L, Kuss E. Human placental sterylsulfatase. Interaction of the isolated
enzyme with substrates, products, transition-state analogues, amino-acid
modiﬁers and anion transport inhibitors. Biol Chem Hoppe Seyler 1991;
372:173–85.
[63] Woo LL, Purohit A, Malini B, Reed MJ, Potter BV. Potent active site-directed
inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Chem Biol 2000;7:773–91.
